News & Events

Demonstrating quality to stakeholders is critical in oncology marketing

In today’s healthcare landscape, the pharma industry is experiencing a shift from volume to value. This requires pharma marketers to communicate a message of quality to their primary stakeholders and healthcare providers (HCPs).

Not only should quality be demonstrated in the product and brand but also in the general approach to medical marketing.

How credible is your content, and does it communicate standards of quality? Are the channels through which you market your message reliable? How well do they engage your stakeholders? Is the overall experience consistent and does it support a mutually beneficial partnership? These are the questions you need to ask to make sure your marketing strategies support a message of quality.

In the field of oncology specifically, demonstrating quality is one of the pharma marketer’s greatest challenges. But oncology marketing that applies a message of quality can successfully bridge the transition from a volume-based to a value-based model of care, instilling confidence in vital stakeholders. This blog will discuss best practices in demonstrating quality in cancer care; how to measure quality of care; and finally, how to disseminate a message of quality across various marketing channels.

Best practices for demonstrating quality
The challenges of demonstrating quality in the area of cancer care are due in part to simple barriers of communication. The solution as proposed by multidisciplinary oncology stakeholders was to establish best practices for measuring and communicating the topic of quality care.

  • Clearly communicate the standards that guide quality care with all stakeholders, HCPs, and other pharmaceutical professionals.
  • Engage stakeholders to better understand and address their concerns regarding the way in which the quality of care is measured and—in the cancer field—how it is perceived to support oncology products or programs.
  • Prepare to communicate quality measures and metrics as an industry requirement. This is not currently a condition for payer reimbursement, but it may be an adopted standard in the future.
  • Create a consistent message to be disseminated to key stakeholders highlighting the quality of care provided by your brand. Digital channels used to engage stakeholders can be leveraged in order to communicate your message of quality.

Measuring quality of cancer care
Measuring quality is the key to validating the care experience that is to be provided by your product or service. Stakeholders may have different ideas of what constitutes quality in care, and various clinical factors can contribute to the definition of quality in cancer care specifically. While patients measure the quality of care by their overall care experience, including their relationships with providers and financial services, stakeholders often require a more quantitative expression of quality.

Typically, oncology practices need to meet certain data reporting requirements in order to demonstrate quality to stakeholders. This can be a burden, but ultimately to meet the defined standard of quality, the model of care needs to show that it yields the most value to the cancer patient. And while the patient experience is a valid concern, the primary goal for pharma companies is to demonstrate quality in the form of clinical results, metrics, and relevant trial data, which should all support a successful treatment paradigm.

The requirement to demonstrate quality by providing specific measurements and metrics is a current standard established in the pharma industry. It is a good practice for pharma companies to consistently communicate their standard of care to stakeholders and HCPs by providing data that is well documented and published.

Implementing standards of quality into marketing practices
Given the challenges of demonstrating quality in cancer care, how do oncology marketers effectively deliver a message of quality? The first step is to communicate clearly the guiding standards of care established by a panel of stakeholders, and the methods used to measure the quality of care. Second, make sure your oncology marketing campaign includes access to high value content—such as important clinical data used to conclusively prove quality—and maintains a consistent, reliable message across all communications.

Finally, a thoughtfully designed, multichannel approach to oncology marketing can ease communication barriers on the topic of quality care in cancer. Multichannel marketing provides more channels for stakeholders to engage through, and a platform whereby you can create and disseminate a consistent message of quality.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.
Aptitude Health
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.